Skip to content
Back to IRWD

Ironwood Pharmaceuticals Inc

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
17
Purchases
0
Sales
17
Purchase value
$0.00
Sale value
$22.60M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Ronald SilverPFO & PAO
4Rule 10b5-1 plan disclosed
Filed Jul 9, 2026Period of report Jul 7, 20260001193125-26-299749
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 7, 2026
Class A Common StockF1F2127,890$4.52$578.06K313,680Direct
Filing footnotes · 2
  1. F1The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Julie McHughDirector
4Rule 10b5-1 plan disclosed
Filed Jun 17, 2026Period of report Jun 16, 20260001193125-26-274275
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 16, 2026
Class A Common StockF2F321,571$3.73$80.46K250,749Direct
Filing footnotes · 3
  1. F1The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
  2. F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.66 to $3.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Alexander J DennerDirector
4
Filed Mar 17, 2026Period of report Mar 13, 20260001193125-26-111581
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 17, 2026
Class A Common StockF26,725,000$3.05$20.51M9,194,435IndirectSee footnote
SaleMar 17, 2026
Class A Common StockF25,800$3.31$19.20K9,188,635IndirectSee footnote
Filing footnotes · 2
  1. F1Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024.
  2. F2Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of SarissaCapital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.
Open on SEC EDGAR
Gregory S. MartiniChief Financial Officer
4
Filed Feb 25, 2026Period of report Feb 23, 20260001193125-26-071515
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Class A Common StockF1F311,457$3.66$41.93K160,601Direct
SaleFeb 23, 2026
Class A Common StockF1F210,487$3.81$39.96K172,058Direct
Filing footnotes · 3
  1. F1The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Minardo JohnChief Legal Officer
4
Filed Feb 25, 2026Period of report Feb 23, 20260001193125-26-071509
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Class A Common StockF1F319,053$3.66$69.73K363,886Direct
SaleFeb 23, 2026
Class A Common StockF1F217,439$3.81$66.44K382,939Direct
Filing footnotes · 3
  1. F1The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Michael ShetzlineSVP, CMO, Head-Res&Drug
4
Filed Feb 25, 2026Period of report Feb 23, 20260001193125-26-071503
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF1F317,012$3.66$62.26K521,425Direct
SaleFeb 23, 2026
Class A Common StockF1F215,570$3.81$59.32K538,437Direct
Filing footnotes · 3
  1. F1The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Tammi L GaskinsChief Commercial Officer
4
Filed Feb 25, 2026Period of report Feb 23, 20260001193125-26-071500
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Class A Common StockF1F311,239$3.66$41.13K213,738Direct
SaleFeb 23, 2026
Class A Common StockF1F210,287$3.81$39.19K224,977Direct
Filing footnotes · 3
  1. F1The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Thomas A MCCOURTDirector · Chief Executive Officer
4
Filed Feb 25, 2026Period of report Feb 23, 20260001193125-26-071496
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Class A Common StockF1F4103,526$3.66$378.91K1,489,002Direct
SaleFeb 23, 2026
Class A Common StockF1F2F394,757$3.81$361.02K1,592,528Direct
Filing footnotes · 4
  1. F1The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The reporting person acquired 4 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2025.
  4. F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Ronald SilverPrincipal Accounting Officer
4
Filed Feb 25, 2026Period of report Feb 23, 20260001193125-26-071495
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Class A Common StockF1F312,621$3.66$46.19K252,636Direct
SaleFeb 23, 2026
Class A Common StockF1F211,552$3.81$44.01K265,257Direct
Filing footnotes · 3
  1. F1The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Ronald SilverPrincipal Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006290
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 5, 2026
Class A Common StockF1F235,416$4.60$162.91K276,809Direct
Filing footnotes · 2
  1. F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The reporting person acquired 35,416 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2025.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.